Esempio: Heart Attack

Cerca studi clinici per: Sulindac sulfone

Totale 12 risultati

NCT00037609

Completato

Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients

Condizioni: Breast Neoplasms; Metastases, Neoplasm
NCT00283803

Completato

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Condizioni: Prostate Cancer
NCT00166426

Completato

Exisulind Versus Placebo After Surgical Removal of the Prostate

Condizioni: Prostatic Neoplasms
NCT00166478

Completato

Exisulind Prior to Radical Prostatectomy

Condizioni: Prostatic Neoplasms
NCT00085826

Completato

A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients

Condizioni: Non-Small Cell Lung Cancer
NCT00072618

Completato

Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients

Condizioni: NSCLC
NCT00041054

Completato

Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Condizioni: Lung Cancer
NCT00026468

Ritirato

Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis

Condizioni: Colorectal Cancer; Small Intestine Cancer
NCT00078910

Completato

Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer

Condizioni: Prostate Cancer
NCT00052845

Completato

Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Condizioni: Prostate Cancer
NCT00041314

Completato

Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer

Condizioni: Lung Cancer
NCT00039520

Completato

Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

Condizioni: Breast Cancer